_version_ 1783535921878007808
author Färkkilä, Anniina
Gulhan, Doga C.
Casado, Julia
Jacobson, Connor A.
Nguyen, Huy
Kochupurakkal, Bose
Maliga, Zoltan
Yapp, Clarence
Chen, Yu-An
Schapiro, Denis
Zhou, Yinghui
Graham, Julie R.
Dezube, Bruce J.
Munster, Pamela
Santagata, Sandro
Garcia, Elizabeth
Rodig, Scott
Lako, Ana
Chowdhury, Dipanjan
Shapiro, Geoffrey I.
Matulonis, Ursula A.
Park, Peter J.
Hautaniemi, Sampsa
Sorger, Peter K.
Swisher, Elizabeth M.
D’Andrea, Alan D.
Konstantinopoulos, Panagiotis A.
author_facet Färkkilä, Anniina
Gulhan, Doga C.
Casado, Julia
Jacobson, Connor A.
Nguyen, Huy
Kochupurakkal, Bose
Maliga, Zoltan
Yapp, Clarence
Chen, Yu-An
Schapiro, Denis
Zhou, Yinghui
Graham, Julie R.
Dezube, Bruce J.
Munster, Pamela
Santagata, Sandro
Garcia, Elizabeth
Rodig, Scott
Lako, Ana
Chowdhury, Dipanjan
Shapiro, Geoffrey I.
Matulonis, Ursula A.
Park, Peter J.
Hautaniemi, Sampsa
Sorger, Peter K.
Swisher, Elizabeth M.
D’Andrea, Alan D.
Konstantinopoulos, Panagiotis A.
author_sort Färkkilä, Anniina
collection PubMed
description
format Online
Article
Text
id pubmed-7235235
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72352352020-05-20 Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer Färkkilä, Anniina Gulhan, Doga C. Casado, Julia Jacobson, Connor A. Nguyen, Huy Kochupurakkal, Bose Maliga, Zoltan Yapp, Clarence Chen, Yu-An Schapiro, Denis Zhou, Yinghui Graham, Julie R. Dezube, Bruce J. Munster, Pamela Santagata, Sandro Garcia, Elizabeth Rodig, Scott Lako, Ana Chowdhury, Dipanjan Shapiro, Geoffrey I. Matulonis, Ursula A. Park, Peter J. Hautaniemi, Sampsa Sorger, Peter K. Swisher, Elizabeth M. D’Andrea, Alan D. Konstantinopoulos, Panagiotis A. Nat Commun Author Correction Nature Publishing Group UK 2020-05-18 /pmc/articles/PMC7235235/ /pubmed/32424117 http://dx.doi.org/10.1038/s41467-020-16344-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Author Correction
Färkkilä, Anniina
Gulhan, Doga C.
Casado, Julia
Jacobson, Connor A.
Nguyen, Huy
Kochupurakkal, Bose
Maliga, Zoltan
Yapp, Clarence
Chen, Yu-An
Schapiro, Denis
Zhou, Yinghui
Graham, Julie R.
Dezube, Bruce J.
Munster, Pamela
Santagata, Sandro
Garcia, Elizabeth
Rodig, Scott
Lako, Ana
Chowdhury, Dipanjan
Shapiro, Geoffrey I.
Matulonis, Ursula A.
Park, Peter J.
Hautaniemi, Sampsa
Sorger, Peter K.
Swisher, Elizabeth M.
D’Andrea, Alan D.
Konstantinopoulos, Panagiotis A.
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title_full Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title_fullStr Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title_full_unstemmed Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title_short Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title_sort author correction: immunogenomic profiling determines responses to combined parp and pd-1 inhibition in ovarian cancer
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235235/
https://www.ncbi.nlm.nih.gov/pubmed/32424117
http://dx.doi.org/10.1038/s41467-020-16344-z
work_keys_str_mv AT farkkilaanniina authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT gulhandogac authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT casadojulia authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT jacobsonconnora authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT nguyenhuy authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT kochupurakkalbose authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT maligazoltan authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT yappclarence authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT chenyuan authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT schapirodenis authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT zhouyinghui authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT grahamjulier authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT dezubebrucej authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT munsterpamela authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT santagatasandro authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT garciaelizabeth authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT rodigscott authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT lakoana authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT chowdhurydipanjan authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT shapirogeoffreyi authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT matulonisursulaa authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT parkpeterj authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT hautaniemisampsa authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT sorgerpeterk authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT swisherelizabethm authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT dandreaaland authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT konstantinopoulospanagiotisa authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer